The current stock price of XRAY is 13.76 USD. In the past month the price increased by 10.26%. In the past year, price decreased by -26.65%.
ChartMill assigns a technical rating of 6 / 10 to XRAY. When comparing the yearly performance of all stocks, XRAY is a bad performer in the overall market: 68.81% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to XRAY. There are concerns on the financial health of XRAY while its profitability can be described as average.
Over the last trailing twelve months XRAY reported a non-GAAP Earnings per Share(EPS) of 1.58. The EPS decreased by -14.59% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.6% | ||
| ROE | -59.68% | ||
| Debt/Equity | 1.36 |
22 analysts have analysed XRAY and the average price target is 12.86 USD. This implies a price decrease of -6.55% is expected in the next year compared to the current price of 13.76.
For the next year, analysts expect an EPS growth of -1.98% and a revenue growth -4.27% for XRAY
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 18 | 15.925B | ||
| SOLV | SOLVENTUM CORP | 12.05 | 13.352B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.75 | 12.601B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.99 | 4.721B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.44 | 4.301B | ||
| ICUI | ICU MEDICAL INC | 18.79 | 3.695B | ||
| HAE | HAEMONETICS CORP/MASS | 10.81 | 3.044B | ||
| NEOG | NEOGEN CORP | 32.33 | 2.301B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.67 | 1.975B |
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 14,000 full-time employees. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.
DENTSPLY SIRONA INC
13320 Ballantyne Corporate Place
Charlotte NORTH CAROLINA 28277 US
CEO: Donald M. Casey
Employees: 14000
Phone: 18445463722
Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 14,000 full-time employees. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.
The current stock price of XRAY is 13.76 USD. The price increased by 9.82% in the last trading session.
DENTSPLY SIRONA INC (XRAY) has a dividend yield of 5.17%. The yearly dividend amount is currently 0.62.
XRAY has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
The next ex-dividend date for DENTSPLY SIRONA INC (XRAY) is December 26, 2025.
DENTSPLY SIRONA INC (XRAY) currently has 14000 employees.
The outstanding short interest for DENTSPLY SIRONA INC (XRAY) is 7.41% of its float.